The 2^nd mRNA Process Development & Manufacturing Summit returned to Boston as the most comprehensive and technical industry dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design and automated large-scale manufacturing, to ultimately reduce costs of mRNA production whilst harmonizing with regulatory expectations.   

60+ world-class industry experts including leading mRNA players from Moderna, BioNTech, CureVac, Pfizer and more took center stage across 3 jam-packed days, with 3 deep-dive content tracks on research scale, IND-enabling & clinical scale, and commercial scale covering key areas from plasmid DNA manufacturing, in vitro transcription, purification and mRNA drug product development to help accelerate your mRNA drugs into the clinic and through to market. 

Attendees were able to join  200+ VPs, Directors and Heads of Process Development, Drug Substance, CMC, and MSAT at the world’s only end-to-end meeting enabling scalable, cost-effective and commercially viable global mRNA production.